Rallybio Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +138.5% | +75.8% | +53.2% | -10.2% | -12.7% | -29.8% | |
| – | +262.9% | +417.8% | +160.6% | +15.0% | -26.8% | -33.5% | |
| – | +404.8% | +63.7% | +190.1% | – | – | – | |
| – | +2.4% | -278.3% | – | – | -106.0% | – | |
| – | -27.1% | +143.1% | -83.8% | -77.8% | -100.0% | – | |
| – | +1,002.1% | +12.6% | +4,708.0% | – | +21.1% | +41.1% | |
| – | – | – | -99.7% | +30.0% | -78.0% | -74.2% | |
| – | +359.0% | -42.7% | -38.4% | -99.7% | +3,535.7% | -99.7% | |
| – | +638.5% | -70.9% | -437.2% | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.